MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report)’s share price shot up 7.6% during trading on Friday . The stock traded as high as $1.32 and last traded at $1.28. Approximately 241,762 shares were traded during mid-day trading, an increase of 80% from the average session volume of 134,123 shares. The stock had previously closed at $1.19.
MyMD Pharmaceuticals Stock Performance
The stock has a 50 day moving average price of $1.27 and a two-hundred day moving average price of $1.55.
MyMD Pharmaceuticals Company Profile
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
See Also
- Five stocks we like better than MyMD Pharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Using the MarketBeat Stock Split Calculator
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- How to Start Investing in Real Estate
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
